SOP for Mass-Vaccination Trial Logistics (Multi-Site)

{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/sop-for-mass-vaccination-trial-logistics-multi-site”
},
“headline”: “SOP for Mass-Vaccination Trial Logistics (Multi-Site)”,
“description”: “This SOP defines standardized procedures for planning, coordination, and execution of mass-vaccination trial logistics across multiple sites. It ensures compliance with FDA, EMA, CDSCO, WHO, and ICH GCP guidelines, covering cold chain management, shipment validation, accountability, and multi-site coordination.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}

Published on 24/12/2025

Standard Operating Procedure for Mass-Vaccination Trial Logistics (Multi-Site)

SOP No.	CR/OPS/118/2025
Supersedes	NA
Page No.	1 of 65
Issue Date	26/08/2025
Effective Date	01/09/2025
Review Date	01/09/2026

Table of Contents

Purpose

The purpose of this SOP is to define standardized procedures for logistics planning and execution in multi-site mass-vaccination trials. It ensures that investigational vaccines are

distributed, stored, and administered under validated conditions, maintaining compliance with global regulatory guidelines and safeguarding subject safety.

Scope

This SOP applies to sponsors, CROs, investigators, site pharmacists, couriers, and logistics vendors involved in multi-site vaccine trials. It covers supply chain planning, shipment validation, cold-chain management, accountability, coordination between multiple sites, and inspection readiness.

Responsibilities

Sponsor: Oversees supply chain planning and ensures validated logistics systems.
Investigator: Ensures site-level receipt, storage, and accountability of vaccines.
Logistics Vendor/Courier: Ensures validated transport conditions and documentation.
CRO: Monitors site compliance with logistics and distribution requirements.
Site Staff: Maintain records of receipt, storage, and administration of vaccines.
QA: Reviews logistics records and audits vendors/sites for compliance.

Accountability

The Sponsor’s Clinical Supply Chain Manager is accountable for ensuring validated logistics processes across all participating sites. Site Investigators are accountable for site-level vaccine accountability and storage compliance.

Procedure

1. Supply Chain Planning
1.1 Develop a logistics plan for multi-site vaccine distribution.
1.2 Define site allocation, shipment schedules, and buffer stocks.
1.3 Document in Supply Chain Planning Log (Annexure-1).

2. Shipment Validation
2.1 Validate shippers with temperature monitoring devices.
2.2 Ensure SOP-driven courier training.
2.3 Record details in Shipment Validation Log (Annexure-2).

3. Vaccine Receipt
3.1 Verify shipment integrity and temperature compliance.
3.2 Document in Vaccine Receipt Log (Annexure-3).

4. Cold-Chain Management
4.1 Store vaccines in validated cold storage (+2°C to +8°C or as specified).
4.2 Document daily temperatures in Cold-Chain Monitoring Log (Annexure-4).

5. Site Coordination
5.1 Ensure real-time communication between sponsor, CRO, and site teams.
5.2 Record updates in Site Coordination Log (Annexure-5).

6. Accountability
6.1 Reconcile doses received, administered, returned, or destroyed.
6.2 Record in Vaccine Accountability Log (Annexure-6).

7. Deviation Management
7.1 Record all deviations (e.g., delays, temperature excursions).
7.2 Document corrective actions in Deviation Log (Annexure-7).

8. Archiving
8.1 Archive all multi-site logistics records in TMF and ISF.
8.2 Retain per regulatory timelines (min. 15–25 years).

Abbreviations

SOP: Standard Operating Procedure
CRO: Contract Research Organization
QA: Quality Assurance
IP: Investigational Product
TMF: Trial Master File
ISF: Investigator Site File
GCP: Good Clinical Practice
FDA: Food and Drug Administration
EMA: European Medicines Agency
CDSCO: Central Drugs Standard Control Organization
WHO: World Health Organization

Documents

Supply Chain Planning Log (Annexure-1)
Shipment Validation Log (Annexure-2)
Vaccine Receipt Log (Annexure-3)
Cold-Chain Monitoring Log (Annexure-4)
Site Coordination Log (Annexure-5)
Vaccine Accountability Log (Annexure-6)
Deviation Log (Annexure-7)

References

Version: 1.0

Approval Section

Prepared By	Ravi Kumar, Vaccine Logistics Officer
Checked By	Sunita Reddy, QA Officer
Approved By	Dr. Anil Sharma, Head Clinical Operations

Annexures

Annexure-1: Supply Chain Planning Log

Date	Trial ID	Sites Planned	Coordinator	Status
01/09/2025	VAC-MASS-01	Site-1, Site-2, Site-3	Supply Chain Manager	Planned

Annexure-2: Shipment Validation Log

Date	Shipment ID	Validation Result	Checked By	Status
02/09/2025	SHIP-201	Valid	QA Officer	Approved

Annexure-3: Vaccine Receipt Log

Date	Shipment ID	Received By	Condition	Status
03/09/2025	SHIP-201	Site Pharmacist	Acceptable	Verified

Annexure-4: Cold-Chain Monitoring Log

Date	Storage Unit	Min Temp	Max Temp	Reviewed By
04/09/2025	FRZ-02	+2°C	+7°C	QA Officer

Annexure-5: Site Coordination Log

Date	Sites Covered	Update	Coordinator	Status
05/09/2025	Site-1, Site-2	Shipment Arrived	Logistics Coordinator	Confirmed

Annexure-6: Vaccine Accountability Log

Date	Site	Doses Received	Doses Administered	Doses Remaining
06/09/2025	Site-1	500	300	200

Annexure-7: Deviation Log

Date	Deviation	Impact	Corrective Action	Approved By
07/09/2025	Shipment Delay	Moderate	Re-scheduled doses	QA Officer

Revision History

Revision Date	Revision No.	Revision Details	Reason for Revision	Approved By
26/08/2025	00	Initial version	New SOP creation	Head Clinical Operations

For more SOPs visit: Pharma SOP